Potassium Carbonate → (S)-N-[3-[3-fluoro-4-[4-(morpholin-4-ylcarbonyl)piperazin-1-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]acetamide
反応式
[F:1][C:2]1[CH:3]=[C:4]([N:14]2[CH2:18][C@H:17]([CH2:19][NH:20][C:21](=[O:23])[CH3:22])[O:16][C:15]2=[O:24])[CH:5]=[CH:6][C:7]=1[N:8]1[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]1.[C:25](=[O:28])([O-])[O-].[K+].[K+]>CN(C)C=O>[F:1][C:2]1[CH:3]=[C:4]([N:14]2[CH2:18][C@H:17]([CH2:19][NH:20][C:21](=[O:23])[CH3:22])[O:16][C:15]2=[O:24])[CH:5]=[CH:6][C:7]=1[N:8]1[CH2:13][CH2:12][N:11]([C:15]([N:14]2[CH2:18][CH2:25][O:28][CH2:3][CH2:4]2)=[O:16])[CH2:10][CH2:9]1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
(S)-N-[3-[3-Fluoro-4-[piperazin-1-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]acetamide (154 mg, 0.4587 mmol) was treated with morphonylcarbonylchloride (82 mg, 0.5504 mmol) and anhydrous potassium carbonate (190 mg, 1.376 mmol) in dimethylformamide (10 ml). The reaction mixture was allowed to react at 30° C. for 8 hrs, after which the reaction mixture was extracted with ethylacetate and water. The organic phase was separated and evaporated under reduced pressure to afford crude product. The crude was purified by column chromatography using silica gel using ethylacetate and methanol (9:1) as the eluent to afford pure title compound as colourless solid (85 mg).
後処理
- customto react at 30° C. for 8 hrs
- extractionafter which the reaction mixture was extracted with ethylacetate and water
- customThe organic phase was separated
- customevaporated under reduced pressure
- customto afford crude product
- customThe crude was purified by column chromatography
出典と根拠
- ORDレコード
- ord-9ac465ecbcd7465d989e512bf3335437
- 出典データセット
- uspto-grants-2007_05
- 特許番号
- US07217726B2
反応ノート
読み込み中…